Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Precision Biosciences Inc (NQ: DTIL ) 8.960 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Precision Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Lannett And 4 Other Penny Stocks Bought By Insiders March 22, 2022 US stock futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday March 16, 2022 On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was... Via Benzinga Looking Into Precision BioSciences's Return On Capital Employed March 16, 2022 Precision BioSciences (NASDAQ:DTIL) brought in sales totaling $6.34 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 97.62%, resulting in... Via Benzinga 68 Biggest Movers From Yesterday March 16, 2022 Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session March 15, 2022 Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 164.2% to $60.5 during Tuesday's regular session. Incannex Healthcare's stock is trading at a volume of 664.5K... Via Benzinga The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial March 15, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Recap: Precision BioSciences Q4 Earnings March 15, 2022 Precision BioSciences (NASDAQ:DTIL) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Precision BioSciences Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update March 15, 2022 From Precision BioSciences, Inc. Via Business Wire Earnings Scheduled For March 15, 2022 March 15, 2022 Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi... Via Benzinga Preview: Precision BioSciences's Earnings March 14, 2022 Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement.... Via Benzinga Precision BioSciences to Present at the 40th Annual J.P. Morgan Health Care Conference January 04, 2022 From Precision BioSciences, Inc. Via Business Wire The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings March 13, 2022 Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... Via Benzinga Precision BioSciences Completes Spin-Out of Elo Life Systems December 21, 2021 From Precision BioSciences, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Wednesday January 05, 2022 Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... Via Benzinga Precision BioSciences Reports Clinical Program Updates for Its Allogeneic CAR T Pipeline December 11, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021 December 06, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Present Preclinical Gene Editing Data on its ARCUS-Based Chronic Hepatitis B Program at the HEP DART 2021 Conference December 03, 2021 From Precision BioSciences, Inc. Via Business Wire The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More December 06, 2021 The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Thursday's After-Market Session November 18, 2021 Gainers NeuroOne Medical Tech (NASDAQ:NMTC... Via Benzinga Precision BioSciences Earnings Perspective: Return On Capital Employed November 11, 2021 Benzinga Pro data, Precision BioSciences (NASDAQ:DTIL) reported Q3 sales of $24.04 million. Earnings fell to a loss of $11.27 million, resulting in a 152.09% decrease from last... Via Benzinga Precision BioSciences Reports Third Quarter 2021 Financial Results and Provides Business Update November 10, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Earnings Preview November 09, 2021 Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement.... Via Benzinga Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting November 09, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Appoints Sam Wadsworth, Ph.D. and Shari Lisa Piré, J.D. to Board of Directors November 08, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy for Relapsed and Refractory B-cell Malignancies at the 63rd Annual Meeting of the American Society of Hematology November 04, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Report Third Quarter 2021 Financial Results on November 10, 2021 and Participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021 November 03, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Present at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 27, 2021 October 21, 2021 From Precision BioSciences, Inc. Via Business Wire The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review October 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19... Via Benzinga Precision BioSciences Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pursuant to Nasdaq Listing Rule 5635(c)(4) September 27, 2021 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Appoints Michael Amoroso Chief Executive Officer September 27, 2021 From Precision BioSciences, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.